Cargando…
Mucosal Immune Responses to Respiratory Syncytial Virus
Despite over half a century of research, respiratory syncytial virus (RSV)-induced bronchiolitis remains a major cause of hospitalisation in infancy, while vaccines and specific therapies still await development. Our understanding of mucosal immune responses to RSV continues to evolve, but recent st...
Autores principales: | Barnes, Megan V. C., Openshaw, Peter J. M., Thwaites, Ryan S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997753/ https://www.ncbi.nlm.nih.gov/pubmed/35406717 http://dx.doi.org/10.3390/cells11071153 |
Ejemplares similares
-
The Respiratory Mucosa: Front and Center in Respiratory Syncytial Virus Disease
por: Thwaites, Ryan S., et al.
Publicado: (2019) -
A New Role for CXCL4 in Respiratory Syncytial Virus Disease
por: Wiseman, Dexter J., et al.
Publicado: (2020) -
Durability of Immunity to SARS-CoV-2 and Other Respiratory Viruses
por: Siggins, Matthew K., et al.
Publicado: (2021) -
Respiratory syncytial virus: The virus, the disease and the immune response
por: Ogra, Pearay L.
Publicado: (2004) -
Potential therapeutic implications of new insights into respiratory syncytial virus disease
por: Openshaw, Peter JM
Publicado: (2002)